Stephane Bancel Moderna, Inc. (MRNA) insider trading activity

Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $380 Million. The most recent transaction as insider was on Mar 23, 2022, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M

0% 3M change

1.05% 12M change

Total Value Held $380 Million

Stephane Bancel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 23 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,482,535 Common Stock
Mar 23 2022	SELL Open market or private sale	$1,624,860 $180.54 p/Share	9,000 Reduced 0.16%	5,486,535 Common Stock
Mar 16 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,495,535 Common Stock
Mar 16 2022	SELL Open market or private sale	$1,446,930 $160.77 p/Share	9,000 Reduced 0.16%	5,499,535 Common Stock
Mar 09 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,508,535 Common Stock
Mar 09 2022	SELL Open market or private sale	$1,188,450 $132.05 p/Share	9,000 Reduced 0.16%	5,512,535 Common Stock
Mar 02 2022	SELL Bona fide gift	-	154,000 Reduced 2.71%	5,521,535 Common Stock
Mar 02 2022	SELL Open market or private sale	$1,344,960 $149.44 p/Share	9,000 Reduced 0.16%	5,525,535 Common Stock
Feb 23 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,684,535 Common Stock
Feb 23 2022	SELL Open market or private sale	$1,301,400 $144.6 p/Share	9,000 Reduced 0.16%	5,688,535 Common Stock
Feb 16 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,697,535 Common Stock
Feb 16 2022	SELL Open market or private sale	$1,330,200 $147.8 p/Share	9,000 Reduced 0.16%	5,701,535 Common Stock
Feb 09 2022	SELL Open market or private sale	$1,388,340 $154.26 p/Share	9,000 Reduced 0.16%	5,714,535 Common Stock
Feb 09 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,710,535 Common Stock
Feb 02 2022	SELL Open market or private sale	$1,538,010 $170.89 p/Share	9,000 Reduced 0.16%	5,727,535 Common Stock
Feb 02 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,723,535 Common Stock
Jan 26 2022	SELL Open market or private sale	$1,422,000 $158.0 p/Share	9,000 Reduced 0.16%	5,740,535 Common Stock
Jan 26 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,736,535 Common Stock
Jan 19 2022	SELL Open market or private sale	$1,696,950 $188.55 p/Share	9,000 Reduced 0.16%	5,753,535 Common Stock
Jan 19 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,749,535 Common Stock
Jan 12 2022	SELL Open market or private sale	$1,980,090 $220.01 p/Share	9,000 Reduced 0.16%	5,766,535 Common Stock
Jan 12 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,762,535 Common Stock
Jan 05 2022	SELL Open market or private sale	$2,088,900 $232.1 p/Share	9,000 Reduced 0.16%	5,779,535 Common Stock
Jan 05 2022	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,775,535 Common Stock
Dec 29 2021	SELL Bona fide gift	-	4,000 Reduced 0.07%	5,788,535 Common Stock

Stephane Bancel

Chief Executive Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account